Navigation Links
Marrone Bio Innovations Files Patent for a Unique Bacillus Species
Date:3/27/2013

Davis, CA (PRWEB) March 27, 2013

Marrone Bio Innovations, Inc. (MBI) a leading global provider of natural pest management products for the agricultural and water treatment markets, announces the submission of a patent application encompassing a new Bacillus sp. strain F727, to the United States Patent and Trademark Office. This strain was first discovered from soil collected in California by one of MBI’s employees. The chemistry and genetic profiles appear to be unique from other known Bacillus species. In addition, the anti-fungal compounds produced by this new strain are different than the current commercial Bacillus biofungicide products.

In comparison tests with commonly used chemical fungicides, the Bacillus sp. strain F727 shows a high level of activity against a broad range of fungal and bacterial plant pathogens. In MBI’s greenhouse tests, Bacillus strain F727 outperformed the leading Bacillus biofungicides on the market, particularly on downy mildews, which are difficult to control with both chemicals and biofungicides.

According to Phyllis Himmel, Ph.D., MBI Vice President of Research & Development, Bacillus sp. strain F727 shows consistent fungicidal activity against Botrytis gray mold and downy mildews in plant tests. “We are excited to move this candidate to field trials on a broad range of crops in 2013,” she said. “The strain has also shown activity beyond plant disease control. Additional work is in progress to explore its usefulness as a plant growth promoter in crops such as corn, soybeans, tomatoes and turf.”

Hector Absi, MBI’s Sr. VP of Commercial Operations, stated, “I am excited to have another MBI fungicide/bactericide to enhance our current commercial product, Regalia®. We believe the combination of the two products will provide superior disease control and plant health across a broad range of crops.”

###

About Marrone Bio Innovations
Marrone Bio Innovations, Inc. (MBI) is a leading global provider of biopesticides for the agricultural and water treatment markets. MBI's award-winning products include Regalia® biofungicide, Grandevo®, a broad-spectrum bioinsecticide and Zequanox® the first biological product to selectively control invasive zebra and quagga mussels. MBI has also developed a pipeline of products including several nematicide, fungicide, algaecide and plant health product candidates. The company currently has more than 150 patents pending in the U.S. and internationally.

Read the full story at http://www.prweb.com/releases/2013/3/prweb10577112.htm.


'/>"/>
Source: PRWeb
Copyright©2012 Vocus, Inc.
All rights reserved

Related biology technology :

1. Marrone Bio Innovations Submits New Bioherbicide for EPA Registration
2. Marrone Bio Innovations’ Zequanox® Demonstrates Control of Zebra Mussels in Illinois Lake
3. Marrone Bio Innovations’ CEO to Address European Biopesticide Industry at Informa Life Sciences Biopesticides Conference
4. Marrone Bio Innovations Breaks Ground on Michigan Manufacturing Facility
5. New Opportunity: The Biomedical Innovations of Tomorrow - Research Report on PhotoMedex, Axiall Corp, Varian Medical Systems, Volcano Corporation and Navidea Biopharmaceuticals
6. BioHealth Innovation, Inc. Forms Commercial Relevance Advisory Board to Help Advance Market-Relevant Innovations in Central Maryland
7. Genomic Health Announces Results from Two Studies Demonstrating Innovations in Next Generation Sequencing From Paraffin Tissue, Enhancing Understanding of Tumor Biology
8. Brain Research Foundation 2013 Scientific Innovations Awards To Dr. Jean Hebert and Dr. Brian Litt
9. Prism Awards Honor Innovations in ‘Ubiquitous’ Photonics Technology
10. LATISTA Announces Next-Generation iPad App 2.0 for Construction with Industry Leading Innovations
11. Wake Forest Innovations Partners with Veterinary Bioscience Institute to Develop Educational Programs for Life Science Professionals
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/19/2017)... DUBLIN , Jan 19, 2017 Research ... Market by Profiling Technology, Biomolecules, Cancer Type, Application - Global Opportunity ... ... Report, forecasts that the global market is projected to reach $15,737 ... of 13% from 2016 to 2022. Omic technologies ...
(Date:1/19/2017)... HOUSTON , Jan. 19, 2017 ... formation of its Medical/Clinical Advisory Board.  This new ... who enhance the range and depth of expertise ... its novel prenatal diagnostic tests.  These experts are ... guidance for the company,s product development and commercialization ...
(Date:1/19/2017)... Research and Markets ... has announced the addition of the ... 2025" report to their offering. Report ... provides a detailed analysis on current and future market trends to identify ... market values as the base numbers Key market trends ...
(Date:1/19/2017)... ... January 19, 2017 , ... November Research ... leading biopharmaceutical and medical device manufacturers and regulators, is proud to announce the ... 11-compliant email client designed to provide product vigilance departments with the flexibility and ...
Breaking Biology Technology:
(Date:1/12/2017)... 2017 A new report by Allied Market Research, titled, "Global ... technology market is expected to generate revenue of $10.72 billion by 2022, with an ... Reading ... Allied Market Research Logo ...      (Logo: http://photos.prnewswire.com/prnh/20140911/647229) In the year ...
(Date:1/6/2017)... 2017  SomaLogic announced today that it has ... by iCarbonX, the China -based ... Digital Health Ecosystem that can define each person,s ... biological, behavioral and psychological data, the Internet and ... SomaLogic will provide proteomics data and applications expertise ...
(Date:1/3/2017)... 2017 Onitor, provider of digital health technology ... an innovative biometric data-driven program designed to aid weight ... the 2017 Consumer Electronics Show (CES) in ... U.S., the World Health Organization (WHO), have identified lifestyle ... who are overweight or obese. WHO also states that ...
Breaking Biology News(10 mins):